Cargando…
Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
Escalating health care costs have made it imperative to evaluate the resources required to diagnose and treat major illnesses in Canadians. For Canadian men, lung cancer is not only the most common malignancy, but also the major cancer killer. As of 1994, lung cancer is expected to overtake breast c...
Autores principales: | Evans, W. K., Will, B. P., Berthelot, J. M., Wolfson, M. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033927/ https://www.ncbi.nlm.nih.gov/pubmed/7577481 |
Ejemplares similares
-
Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs
por: Will, B P, et al.
Publicado: (1999) -
First do no harm: extending the debate on the provision of preventive tamoxifen
por: Will, B P, et al.
Publicado: (2001) -
Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada
por: Cressman, Sonya, et al.
Publicado: (2014) -
Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada
por: Attard, C.L., et al.
Publicado: (2010) -
The effect of diagnostic assessment programs on the diagnosis and treatment of patients with lung cancer in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2021)